According to IMARC Group latest report titled” Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the market is currently witnessing strong growth. The Global Biologics market size to exhibit moderate growth during the next five years. Biologics, or biologic drugs, refer to medicines made from products derived from animals, humans or microorganisms by applying biotechnology. Some of the common biologics include blood, recombinant proteins, vaccines, and stem cell therapies. As compared to non-biological treatments, these drugs are more target-mediated, sensitive to light and heat, and have to be administered through infusion or injection. Biologic therapies help treat psoriasis, rheumatoid arthritis, diabetes, hemophilia, and forms of leukemia and lymphoma.

Get a sample copy of this Report: https://www.imarcgroup.com/biologics-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Trends:

A significant rise in the prevalence of target chronic diseases is majorly fueling the global biologics market growth. The outbreak of coronavirus (COVID-19) disease has prompted biopharma companies across the globe to heavily invest in vaccines, diagnostics, and therapies. This is further affecting the growth of the market positively. Moreover, leading players have been focusing on the development of novel biologic therapeutics for treating different forms of cancers, which is contributing to the market growth.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/biologics-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi

Biologics Market Segmentation:

Our report has categorized the market based on Region, Source, Product, Disease and Manufacturing.

Breakup by Source:

• Microbial
• Mammalian
• Others

Breakup by Product:

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense, RNAi and Molecular Therapy
• Others

Breakup by Disease:

• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

 Breakup by Manufacturing:

• Outsourced
• In-House

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

• Market Performance (2015-2020)
• Market Outlook (2021- 2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800